Type to search

Pharmaceuticals: Strong Medicine

The pharmaceutical industry has made strong moves in Latin America. High volumes and healthy market growth are driving investment decisions, but hurdles remain. In April 2013, the Brazilian health minister, Alexandre Padilha, flew down to São Paulo to unveil a series of eight agreements with manufacturers to produce 10 drugs locally and some $3.5 billion in low-cost loans to foster innovation. “The least the government spends with imports, the greater the number of medicines the government will be able to supply the national health service (locally known as SUS) for free,” he said. Last year, Brazil’s pharmaceutical industry registered a […]
To read this post, you must purchase a Latin Trade Business Intelligence Subscription.

Next Up

Scroll to top of page